States Win 1st OK Of $400M Sandoz Generic Price-Fixing Deal
A Connecticut federal judge granted preliminary approval Friday to a $400 million settlement between a coalition of states, Sandoz Inc. and its subsidiary Fougera Pharmaceuticals Inc. over allegations of generic drug...To view the full article, register now.
Already a subscriber? Click here to view full article